These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29686038)

  • 21. Lung hypoplasia--a possible teratogenic effect of valproate. Case report.
    Janas MS; Arrøe M; Hansen SH; Graem N
    APMIS; 1998 Feb; 106(2):300-4. PubMed ID: 9531963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A girl with foetal valproate syndrome and autism spectrum disorder].
    Solignac I
    Tijdschr Psychiatr; 2016; 58(3):228-31. PubMed ID: 26979855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiepileptic drug use during pregnancy: perinatal outcomes.
    Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A
    Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter to the editor. Discordant twins for neural tube defect on treatment with sodium valproate.
    Davidson DL
    Seizure; 2002 Oct; 11(7):445. PubMed ID: 12237071
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metopic suture craniosynostosis: sodium valproate teratogenic effect. Case report].
    Assencio-Ferreira VJ; Abraham R; Veiga JC; Santos KC
    Arq Neuropsiquiatr; 2001 Jun; 59(2-B):417-20. PubMed ID: 11460190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A male with fetal valproate syndrome and autism.
    Williams PG; Hersh JH
    Dev Med Child Neurol; 1997 Sep; 39(9):632-4. PubMed ID: 9344057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semax corrects brain dysfunction caused by prenatal introduction of valproic acid.
    Malyshev AV; Razumkina EV; Dubynin VA; Myasoedov NF
    Dokl Biol Sci; 2013 May; 450():126-9. PubMed ID: 23821048
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neuropsychological outcome following intrauterine exposure to valproate].
    Schmitz B; Krämer G; Helmstädter C; Jokeit H; Koch S; Luef G; Schaefer C
    Nervenarzt; 2006 Aug; 77(8):901-11. PubMed ID: 16670922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed effects of drug exposure during pregnancy: reproductive function.
    Sonawane BR; Yaffe SJ
    Biol Res Pregnancy Perinatol; 1983; 4(2):48-55. PubMed ID: 6411137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital nasolacrimal duct obstruction requiring external dacryocystorhinostomies in a child with foetal valproate syndrome.
    Hornby SJ; Welham RA
    Eye (Lond); 2003 May; 17(4):546-7. PubMed ID: 12802369
    [No Abstract]   [Full Text] [Related]  

  • 32. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero.
    Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
    Acta Neurol Scand; 2013 Oct; 128(4):228-34. PubMed ID: 23461556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic drugs and neurocognitive development.
    Klein P; Mathews GC
    Neurology; 2014 Jan; 82(3):194-5. PubMed ID: 24401684
    [No Abstract]   [Full Text] [Related]  

  • 34. Cognitive outcome after exposure to antiepileptic drugs in utero.
    Battino D
    Lancet Neurol; 2009 Jul; 8(7):600-1. PubMed ID: 19539227
    [No Abstract]   [Full Text] [Related]  

  • 35. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental neurotoxicity and anticonvulsant drugs: a possible link.
    Verrotti A; Scaparrotta A; Cofini M; Chiarelli F; Tiboni GM
    Reprod Toxicol; 2014 Sep; 48():72-80. PubMed ID: 24803404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero.
    Stoll C; Audeoud F; Gaugler C; Bernardin A; Messer J
    Genet Couns; 2003; 14(3):289-98. PubMed ID: 14577673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.
    Baker GA; Bromley RL; Briggs M; Cheyne CP; Cohen MJ; García-Fiñana M; Gummery A; Kneen R; Loring DW; Mawer G; Meador KJ; Shallcross R; Clayton-Smith J;
    Neurology; 2015 Jan; 84(4):382-90. PubMed ID: 25540307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longer term outcome of children born to mothers with epilepsy.
    Shorvon SD
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1517-8. PubMed ID: 15489379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.